A Study of ERAS-007 in Patients With Advanced Gastrointestinal Malignancies

NCT05039177 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

101

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Colorectal Cancer
Metastatic Pancreatic Ductal Adenocarcinoma

Interventions

DRUG: ERAS-007
DRUG: Encorafenib
DRUG: Cetuximab
DRUG: Palbociclib

Sponsor

Erasca, Inc.